Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
February 9, 2017
Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts
Katherine B Schuetze, Matthew S Stratton, Weston W Blakeslee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 24, 2014
Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition
Sama F Sleiman, David E Olson, Megan W Bourassa, et al.
Neuroscience Letters
|
July 2, 2013
FDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors
Frederick A Schroeder, Daniel B Chonde, Misha M Riley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2012
Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells
Stefan Kubicek, Joshua C Gilbert, Dina Fomina-Yadlin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 11, 2011
AKT kinase activity is required for lithium to modulate mood-related behaviors in mice
Jen Q Pan, Michael C Lewis, Josh K Ketterman, et al.
Bioorganic & Medicinal Chemistry
|
July 6, 2016
Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors
Florence F Wagner, Michel Weïwer, Stefan Steinbacher, et al.
Plos One
|
August 23, 2013
A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests
Frederick A Schroeder, Michael C Lewis, Daniel M Fass, et al.
Science Translational Medicine
|
May 22, 2020
Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome
Patrick K McCamphill, Laura J Stoppel, Rebecca K Senter, et al.
Scientific Reports
|
April 28, 2021
HDAC2 targeting stabilizes the CoREST complex in renal tubular cells and protects against renal ischemia/reperfusion injury
David D Aufhauser, Paul Hernandez, Seth J Concors, et al.
Cancer Cell
|
November 16, 2010
Hdac3 is essential for the maintenance of chromatin structure and genome stability
Srividya Bhaskara, Sarah K Knutson, Guochun Jiang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
The Journal of Pharmacology and Experimental Therapeutics
|
February 9, 2017
Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts
Katherine B Schuetze, Matthew S Stratton, Weston W Blakeslee, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 24, 2014
Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition
Sama F Sleiman, David E Olson, Megan W Bourassa, et al.
Neuroscience Letters
|
July 2, 2013
FDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors
Frederick A Schroeder, Daniel B Chonde, Misha M Riley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 22, 2012
Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells
Stefan Kubicek, Joshua C Gilbert, Dina Fomina-Yadlin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 11, 2011
AKT kinase activity is required for lithium to modulate mood-related behaviors in mice
Jen Q Pan, Michael C Lewis, Josh K Ketterman, et al.
Bioorganic & Medicinal Chemistry
|
July 6, 2016
Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors
Florence F Wagner, Michel Weïwer, Stefan Steinbacher, et al.
Plos One
|
August 23, 2013
A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests
Frederick A Schroeder, Michael C Lewis, Daniel M Fass, et al.
Science Translational Medicine
|
May 22, 2020
Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome
Patrick K McCamphill, Laura J Stoppel, Rebecca K Senter, et al.
Scientific Reports
|
April 28, 2021
HDAC2 targeting stabilizes the CoREST complex in renal tubular cells and protects against renal ischemia/reperfusion injury
David D Aufhauser, Paul Hernandez, Seth J Concors, et al.
Cancer Cell
|
November 16, 2010
Hdac3 is essential for the maintenance of chromatin structure and genome stability
Srividya Bhaskara, Sarah K Knutson, Guochun Jiang, et al.
Page
of 4